Terms: = Ovarian cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Diagnosis
4 results:
1. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/smad2/3 signaling pathway in ovarian cancer.
Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
[TBL] [Abstract] [Full Text] [Related]
2. Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance.
Dos Santos MV; Holth A; Bischof K; Davidson B
Clin Exp Metastasis; 2024 Feb; 41(1):69-76. PubMed ID: 38141113
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-β pathway via miR-148a-3p/AGO1 axis.
Wu Y; Gu W; Han X; Jin Z
J Cell Mol Med; 2021 Sep; 25(17):8229-8243. PubMed ID: 34288373
[TBL] [Abstract] [Full Text] [Related]
4. Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells.
Li FF; Liu JJ; Liu DW; Lin B; Hao YY; Cong JP; Zhu LC; Gao S; Zhang SL; Iwamori M
Int J Oncol; 2012 Apr; 40(4):1196-202. PubMed ID: 22179544
[TBL] [Abstract] [Full Text] [Related]
